Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14,020 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial.
Beulens JW, Patel A, Vingerling JR, Cruickshank JK, Hughes AD, Stanton A, Lu J, McG Thom SA, Grobbee DE, Stolk RP; AdRem project team; ADVANCE management committee. Beulens JW, et al. Among authors: patel a. Diabetologia. 2009 Oct;52(10):2027-36. doi: 10.1007/s00125-009-1457-x. Epub 2009 Jul 25. Diabetologia. 2009. PMID: 19633827 Free article. Clinical Trial.
Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial.
de Galan BE, Zoungas S, Chalmers J, Anderson C, Dufouil C, Pillai A, Cooper M, Grobbee DE, Hackett M, Hamet P, Heller SR, Lisheng L, MacMahon S, Mancia G, Neal B, Pan CY, Patel A, Poulter N, Travert F, Woodward M; ADVANCE Collaborative group. de Galan BE, et al. Among authors: patel a. Diabetologia. 2009 Nov;52(11):2328-2336. doi: 10.1007/s00125-009-1484-7. Epub 2009 Aug 18. Diabetologia. 2009. PMID: 19688336
Intensive glucose control and risk of cancer in patients with type 2 diabetes.
Stefansdottir G, Zoungas S, Chalmers J, Kengne AP, Knol MJ, Leufkens HG, Patel A, Woodward M, Grobbee DE, De Bruin ML. Stefansdottir G, et al. Among authors: patel a. Diabetologia. 2011 Jul;54(7):1608-14. doi: 10.1007/s00125-011-2104-x. Epub 2011 Apr 21. Diabetologia. 2011. PMID: 21509444 Clinical Trial.
Intensification of medication and glycaemic control among patients with type 2 diabetes - the ADVANCE trial.
van Dieren S, Kengne AP, Chalmers J, Beulens JW, Davis TM, Fulcher G, Heller SR, Patel A, Colagiuri S, Hamet P, Mancia G, Marre M, Neal B, Williams B, Peelen LM, van der Schouw YT, Woodward M, Zoungas S. van Dieren S, et al. Among authors: patel a. Diabetes Obes Metab. 2014 May;16(5):426-32. doi: 10.1111/dom.12238. Epub 2013 Dec 16. Diabetes Obes Metab. 2014. PMID: 24251579 Clinical Trial.
The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron-MR Controlled Evaluation (ADVANCE) Study.
Kengne AP, Patel A, Colagiuri S, Heller S, Hamet P, Marre M, Pan CY, Zoungas S, Grobbee DE, Neal B, Chalmers J, Woodward M; ADVANCE Collaborative Group. Kengne AP, et al. Among authors: patel a. Diabetologia. 2010 May;53(5):821-31. doi: 10.1007/s00125-010-1681-4. Epub 2010 Feb 17. Diabetologia. 2010. PMID: 20157695 Clinical Trial.
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes.
Zoungas S, Chalmers J, Neal B, Billot L, Li Q, Hirakawa Y, Arima H, Monaghan H, Joshi R, Colagiuri S, Cooper ME, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Lisheng L, Mancia G, Marre M, Matthews DR, Mogensen CE, Perkovic V, Poulter N, Rodgers A, Williams B, MacMahon S, Patel A, Woodward M; ADVANCE-ON Collaborative Group. Zoungas S, et al. Among authors: patel a. N Engl J Med. 2014 Oct 9;371(15):1392-406. doi: 10.1056/NEJMoa1407963. Epub 2014 Sep 19. N Engl J Med. 2014. PMID: 25234206 Free article. Clinical Trial.
Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds.
Zoungas S, Chalmers J, Ninomiya T, Li Q, Cooper ME, Colagiuri S, Fulcher G, de Galan BE, Harrap S, Hamet P, Heller S, MacMahon S, Marre M, Poulter N, Travert F, Patel A, Neal B, Woodward M; ADVANCE Collaborative Group. Zoungas S, et al. Among authors: patel a. Diabetologia. 2012 Mar;55(3):636-43. doi: 10.1007/s00125-011-2404-1. Epub 2011 Dec 21. Diabetologia. 2012. PMID: 22186981 Clinical Trial.
Prediction of 10-year vascular risk in patients with diabetes: the AD-ON risk score.
Woodward M, Hirakawa Y, Kengne AP, Matthews DR, Zoungas S, Patel A, Poulter N, Grobbee R, Cooper M, Jardine M, Chalmers J; ADVANCE Collaborative Group. Woodward M, et al. Among authors: patel a. Diabetes Obes Metab. 2016 Mar;18(3):289-94. doi: 10.1111/dom.12614. Epub 2016 Jan 15. Diabetes Obes Metab. 2016. PMID: 26661693
14,020 results
You have reached the last available page of results. Please see the User Guide for more information.